| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/06/1991 | CA2031066A1 Pharmaceutical compositions |
| 06/05/1991 | EP0430539A2 Ocular implants |
| 06/05/1991 | EP0430491A2 Transdermal delivery device for estradiol and process for manufacturing said device |
| 06/05/1991 | EP0430474A1 Sustained release compositions for treating periodontal disease |
| 06/05/1991 | EP0430414A1 Morphine hydrochloride preparation for rectal administration |
| 06/05/1991 | EP0430287A2 Sustained-release drug dosage units |
| 06/05/1991 | EP0430149A2 Pharmaceutical preparations |
| 06/05/1991 | EP0430019A2 Transdermal therapeutic system containing buprenorphine as an active component |
| 06/05/1991 | EP0429856A2 Pharmaceutical preparation containing a metal salt of ibuprofen and process for making same |
| 06/05/1991 | EP0429842A2 Device for the transdermal administration of protein or peptide drug |
| 06/05/1991 | EP0429832A2 Pressed core without sustained drug release, process for its preparation and use of polyhydroxybutyric acid for making such a pressed core |
| 06/05/1991 | EP0429732A1 Sustained-release compositions containing cation exchange resins and polycarboxylic polymers |
| 06/05/1991 | EP0429679A1 Potassium-supplementing preparation |
| 06/05/1991 | EP0190292B1 Pharmaceutical preparation |
| 06/05/1991 | CN1051860A Preparation method of aerosol agent for prevention of flu |
| 06/05/1991 | CN1051859A Preparaing technology of extracted substance of lei gong gambogl and its beta-ring dextrin envelop matter |
| 06/05/1991 | CA2031376A1 Single layer transdermal drug administration system |
| 06/04/1991 | US5021570 Aqueous solution containing fat-soluble vitamin K |
| 06/04/1991 | US5021554 Process for protein particle size reduction using a fluid-energy mill |
| 06/04/1991 | US5021477 Polysiloxane-grafted copolymer topical binder composition with novel hydrophilic monomers and method of coating therewith |
| 06/04/1991 | US5021457 Administering phenylpropanoamine |
| 06/04/1991 | US5021416 Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
| 06/04/1991 | US5021242 Solid drug preparations containing micronized crystals of ebselen |
| 06/04/1991 | US5021241 Long-term sustained-release preparation |
| 06/04/1991 | US5021234 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense |
| 06/04/1991 | US5021200 Process for the production of aqueous dispersions of lipid spheres |
| 06/04/1991 | US5021079 Flat tetrahedronal with iron chloride, preservative for cut flowers |
| 06/04/1991 | US5021053 For delvering drug into mouth of patient |
| 05/31/1991 | CA2030870A1 Pressing not delayed release of active compound, process for its production and use of polyhydroxybutyric acid for the production of such a pressing |
| 05/31/1991 | CA2026354A1 Morphine hydrochloride preparation for rectal administration |
| 05/30/1991 | WO1991007965A1 Mitonaphide infusion solution |
| 05/30/1991 | WO1991007226A1 Production of microparticles |
| 05/30/1991 | WO1991007173A1 Osmotic, oral dosage form for fertility control |
| 05/30/1991 | WO1991007172A1 Oral composition for the treatment of inflammatory bowel diseases |
| 05/30/1991 | WO1991007170A1 Method of producing aqueous mixed-micelle solutions |
| 05/30/1991 | WO1991007169A1 Glyceryl acetate ointment vehicles |
| 05/30/1991 | WO1991007154A1 EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO |
| 05/30/1991 | WO1991007101A1 Methods and compositions for flavoring orally-delivered products |
| 05/30/1991 | CA2059528A1 Mitonafide infusion solution |
| 05/30/1991 | CA2030943A1 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
| 05/29/1991 | EP0429419A2 Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom |
| 05/29/1991 | EP0429248A2 Emulsified composition |
| 05/29/1991 | EP0429225A1 Sustained release compositions for treating periodontal disease |
| 05/29/1991 | EP0429224A1 Use of monoolein in the treatment of the periodontal pocket |
| 05/29/1991 | EP0429187A1 Enhanced bioavailability adsorbates |
| 05/29/1991 | EP0429039A2 Use of an opiate antagonist for the preparation of a pharmaceutical composition to be transdermally administered, and device for transdermal delivery |
| 05/29/1991 | EP0428965A1 Modified starch and process to obtain the same |
| 05/29/1991 | EP0428608A1 Pharmaceutical and/or dietetic compositions containing l-carnitine and l-lysine |
| 05/29/1991 | EP0428585A1 Novel method of administering aspirin and dosage forms containing same |
| 05/29/1991 | EP0428520A1 Antimicrobial composition with long-term activity. |
| 05/29/1991 | CN1051675A Formulation and preparation of spur-pain relieving ointment |
| 05/29/1991 | CN1012662B Thiamine salt granules and their production |
| 05/28/1991 | WO1991007973A1 Fat emulsion |
| 05/28/1991 | US5019584 Therapeutically active chloro substituted benzimidazole |
| 05/28/1991 | US5019579 Antitussive Agents |
| 05/28/1991 | US5019563 Pharmaceutical composition |
| 05/28/1991 | US5019400 Very low temperature casting of controlled release microspheres |
| 05/28/1991 | US5019398 Hydroxypropylmethyl Cellulose, Hydrated Silica |
| 05/28/1991 | US5019397 Aqueous emulsion for pharmaceutical dosage form |
| 05/28/1991 | US5019396 Delivery dispenser for treating cardiac arrhythmias |
| 05/28/1991 | US5019395 Compositions with enhanced penetration |
| 05/28/1991 | US5019394 Liposome composition and its production |
| 05/28/1991 | US5019392 Encapsulation of parasiticides |
| 05/28/1991 | US5019379 Sustained Release Drug Delivery Devices, Bone Cements |
| 05/28/1991 | US5019372 Sustained release |
| 05/28/1991 | US5019369 Method of targeting tumors in humans |
| 05/28/1991 | US5019302 Mixing with meltable binder; using rotatable spreader |
| 05/28/1991 | US5019174 Removing oil from surfaces with liposomal cleaner |
| 05/25/1991 | WO1991007949A1 Delayed release formulations |
| 05/25/1991 | CA2030770A1 Thrombolytic agents |
| 05/23/1991 | CA2030449A1 Prolonged release drug tablet formulations |
| 05/23/1991 | CA2030448A1 Niacin drink mix formulation |
| 05/22/1991 | EP0428352A1 Anti-inflammatory compositions for external use |
| 05/22/1991 | EP0428272A2 Trifluorobenzodiazepine compounds for use in therapy by intraoral administration |
| 05/22/1991 | EP0428169A2 Aqueous liquid formulations |
| 05/22/1991 | EP0428038A2 Transdermal application of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
| 05/22/1991 | EP0427998A2 A pharmaceutical composition for rectal administration of calcitonin |
| 05/22/1991 | EP0427877A1 Adhesive tape preparation of clonidine |
| 05/22/1991 | EP0427741A1 Subsaturated transdermal delivery device |
| 05/22/1991 | EP0427725A1 Water-soluble complexes of pharmaceuticals |
| 05/22/1991 | EP0272265B1 Desintegration tablet and process for its manufacture |
| 05/22/1991 | CN1051508A Contrast media |
| 05/22/1991 | CN1051506A Preparation method of new type sanguisorba pharmaceutical |
| 05/22/1991 | CN1051503A Treatment of conditions and disease |
| 05/22/1991 | CN1051502A Pharmaceutical clavate dosage form and manufacturing method thereof |
| 05/21/1991 | US5017613 Valproic acid preparations |
| 05/21/1991 | US5017609 Storage stability, adrenergic blocking agents |
| 05/21/1991 | US5017607 Levodopa, methyl ester |
| 05/21/1991 | US5017605 Jojoba oil |
| 05/21/1991 | US5017569 Cephalosporin derivatives |
| 05/21/1991 | US5017564 Solid pharmaceutical preparation and method of producing same |
| 05/21/1991 | US5017501 Preparation of uniformly sized liposomes encapsulating an aqueous liquid |
| 05/21/1991 | US5017472 Milk fat globules |
| 05/21/1991 | US5017383 Method of producing fine coated pharmaceutical preparation |
| 05/21/1991 | US5017382 Polyoxyethylene glycol crosslinked, prostaglandin |
| 05/21/1991 | US5017381 Multi-unit pulsatile delivery system |
| 05/21/1991 | US5017378 Intraorgan injection of biologically active compounds contained in slow-release microcapsules or microspheres |
| 05/21/1991 | US5017371 Method for reducing side effects of cancer therapy |
| 05/21/1991 | US5017369 Film-forming teat sealer for prevention of mastitis and use thereof |
| 05/21/1991 | US5017366 Sunscreen, erythromycin |